IPC I PEACE, INC. Logo (WIPO, 20.02.2020)
WIPOSchützen Sie diese Marke vor Nachahmern!
Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.
Die Internationale Marke IPC I PEACE, INC. wurde als Bildmarke am 20.02.2020 bei der Weltorganisation für geistiges Eigentum angemeldet.
Logodesign (Wiener Klassifikation)
#Kreise #Briefe, die eine besondere Form des Schreibens darstellen #Farben #26.01.01 #Kreise, die einen oder mehrere Buchstaben enthalten #Kreise mit dunklen Flächen oder Teilen von Flächen #Serie von Briefen, die verschiedene Formen des Schreibens darstellen #Fünf Farben und mehr
| Markenform | Bildmarke |
| Aktenzeichen | 1548859 |
| Länder | 
|
| Basismarke |
Nr. 88596135,
28. August 2019
|
| Anmeldedatum | 20. Februar 2020 |
| Ablaufdatum | 20. Februar 2030 |
Markeninhaber
809 San Antonio Road, Suite #7
Palo Alto CA 94303
US
Palo Alto CA 94303
US
Markenvertreter
TMI Associates,
23rd Floor, Roppongi Hills Mori Tower,
JP
Waren und Dienstleistungen
10
Apparatus for the regeneration of stem cells for medical
purposes, namely, for gene editing, gene collection, and
gene production
11
Refrigerated medical container for storage, transportation
and cooling of medicines and pharmaceuticals, namely, frozen
storage containers for stem cells
36
Insurance services, namely, underwriting, issuance and
brokerage of stem cell insurance
40
Custom manufacture and non-custom manufacture of medical
devices to order and/or specification of others (term
considered too vague by the International Bureau - Rule 13
(2) (b) of the Regulations); biomanufacturing for others,
namely, custom manufacturing and non-custom manufacturing of
medical and biological materials (term considered too vague
by the International Bureau - Rule 13 (2) (b) of the
Regulations); custom manufacture and non-custom manufacture
of machinery for generating stem cells to order and/or
specification of others (term considered too vague by the
International Bureau - Rule 13 (2) (b) of the Regulations);
biomanufacturing for others, namely, custom manufacturing
and non-custom manufacturing of clinical grade cells (term
considered too vague by the International Bureau - Rule 13
(2) (b) of the Regulations); stem cell banking in the nature
of stem cell freezing services
42
Scientific and medical research in the field of stem cell,
gene research, and gene editing; blood analysis services;
medical and scientific research, namely, testing,
inspection, and research of stem cells; biological cloning
services, namely, organ reproduction services; biological
cloning services, namely, dna, rna and protein reproduction
services; testing, inspection, and research of cosmetics;
collection of biological materials, namely, stem cells for
scientific research purposes; medical and scientific
research services, namely, research in the field of stem
cells and gene diagnostics; dna analysis services for
scientific research purposes; drug discovery services;
scientific research services, namely, research in the field
of regenerative medicine; stem cell and gene expression
analysis for scientific research purposes; stem cell and
epigenetic state analysis for scientific research purposes;
proteomic analysis for scientific research purposes; stem
cell and gene collection services for research purposes
44
Stem cell and gene collection services for medical purposes;
medical analysis services for diagnostic and treatment
purposes provided by medical laboratories in the nature of
stem cell and gene expression analysis; medical analysis
services for diagnostic and treatment purposes provided by
medical laboratories in the nature of stem cell and
epigenetic state analysis; medical analysis services for
diagnostic and treatment purposes provided by medical
laboratories in the nature of proteomic analysis;
healthcare; medical assistance; stem cell therapy and stem
cell production services for medical purposes and research
purposes (term considered too vague by the International
Bureau - Rule 13 (2) (b) of the Regulations); stem cell and
gene banking services; cosmetic surgery services; stem cell
therapy services, namely, stem cell and gene transplantation
services; collection of biological materials, namely, stem
cells for medical treatment purposes; medical analysis
services for diagnostic and treatment purposes provided by
medical laboratories in the nature of stem cell and gene
diagnostic services; medical diagnostic and treatment
services in the field of regenerative medical services
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen
Markenhistorie
| Datum | Belegnummer | Bereich | Eintrag |
|---|---|---|---|
| 09. Februar 2022 | 2022/13 Gaz | US | RAW: Partial Ceasing Effect |
| 13. Januar 2022 | 2022/3 Gaz | JP | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 22. Juli 2021 | 2021/29 Gaz | JP | Ablehnung |
| 20. Februar 2020 | 2020/34 Gaz | US | Eintragung |
ID: 141548859